retatrutide cardiovascular effects vs Survodutide: 24% vs 18% Weight Loss Explained THE EFFECT OF TRIPLE-HORMONE-RECEPTOR AGONIST

In large obesity trials, incident high blood pressure occurred in fewer than 1% of semaglutide users versus about 2% on placebo, suggesting no clear causal link

Rotate injection sites, use correct technique, and maintain cleanliness

8:357ra122

Other benefits of ultra-long-acting GLP-1RAs include less fluctuation in blood concentration, improved gastrointestinal tolerance, and a simpler and more convenient once-a-week dosing regimen that improves the compliance of patients and the persistence of treatment (Gentilella et al., 2019)

It can be difficult for many patients to lose weight using traditional methods such as dieting or exercise

doi: 10.4049/jimmunol.1501783 131 Kedia-MehtaNChoiCMcCruddenALittwitz-SalomonEFoxPGGardinerCMet al